View of Outcomes of Synergistic Effects of Angiotensin Receptor Blocker/Neprilysin Inhibitor (ARNI) and Sodium Glucose Co-Transporter Subtype 2 Inhibitor (SGLT2i) in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) at Ratchaburi Hospital

Return to Article Details Outcomes of Synergistic Effects of Angiotensin Receptor Blocker/Neprilysin Inhibitor (ARNI) and Sodium Glucose Co-Transporter Subtype 2 Inhibitor (SGLT2i) in Patients with Heart Failure with Reduced Ejection Fraction (HFrEF) at Ratchaburi Hospital Download Download PDF